Medicare Part D

AMCP supports the inclusion of prescription drug coverage in all health care benefit programs, including those administered by the government (e.g., Medicare, Medicaid, health insurance exchanges). Access to and proper utilization of a comprehensive prescription drug benefit, have been shown to reduce the severity of and complications arising from many common illnesses. Failure to provide prescription drug coverage can increase the use of more intensive, costly health care services, such as surgery and/or hospitalization. AMCP also supports granting flexibility to managed care organizations to develop clinically sound, evidence-based benefits free from arduous mandates.  
 
(See AMCP Managed Care Pharmacy Practice Positions - Prescription Drug Coverage)

Development of Performance Measures

Policy 0006

02/01/2000 Introduced
02/01/2005 Revised
11/01/2009 Revised
02/21/2018 Revised
02/08/2023 Revised

AMCP recommends the continued development of standardized and reproducible evidence-based quality performance measures that are fair, attainable, meaningful, reproducible, and relevant. AMCP partners with complementary organizations to ensure alignment of all health care stakeholders in the pursuit of measures to improve the quality of patient care.

Medicare Part D Quality Measures

Policy 1403

10/07/2014 Introduced

The Academy recognizes the essential role of pharmacists and plans in improving the quality of care provided to patients and supports a measure development process which allows for timely integration of evidence-based medicine and feedback from stakeholders.  AMCP additionally emphasizes the need to align measures across programs to promote consistency, economic efficiency, and quality across the health care system.

(See also AMCP Future of Medicare Part D Statement - Medicare Part D Quality Measures)